These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36724882)

  • 21. A Meta-Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients.
    Xiao J; Yong JN; Ng CH; Syn N; Lim WH; Tan DJH; Tan EY; Huang D; Wong RC; Chew NWS; Tan EXX; Noureddin M; Siddiqui MS; Muthiah MD
    Liver Transpl; 2022 Apr; 28(4):689-699. PubMed ID: 34626045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, Predictors, and Impact on Survival of Long-term Cardiovascular Events After Liver Transplantation.
    Sastre L; García R; Gándara JG; Ruiz P; Lombardo J; Colmenero J; Navasa M; Crespo G
    Transplantation; 2020 Feb; 104(2):317-325. PubMed ID: 31335770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil.
    D'Avola D; Cuervas-Mons V; Martí J; Ortiz de Urbina J; Lladó L; Jimenez C; Otero E; Suarez F; Rodrigo JM; Gómez MA; Fraga E; Lopez P; Serrano MT; Rios A; Fábrega E; Herrero JI
    Liver Transpl; 2017 Apr; 23(4):498-509. PubMed ID: 28160394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is post-transplant metabolic syndrome associated with pre-liver transplant visceral adipose tissue area?
    Woodward AJ; Wallen MP; Ryan J; Hall A; Ward LC; Coombes JS; Macdonald GA
    Clin Nutr ESPEN; 2020 Oct; 39():61-66. PubMed ID: 32859330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation.
    Sprinzl MF; Weinmann A; Lohse N; Tönissen H; Koch S; Schattenberg J; Hoppe-Lotichius M; Zimmermann T; Galle PR; Hansen T; Otto G; Schuchmann M
    Transpl Int; 2013 Jan; 26(1):67-74. PubMed ID: 23126674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
    Mouchli MA; Singh S; Boardman L; Bruining DH; Lightner AL; Rosen CB; Heimbach JK; Hasan B; Poterucha JJ; Watt KD; Kane SV; Raffals LE; Loftus EV
    Inflamm Bowel Dis; 2018 Apr; 24(5):1074-1081. PubMed ID: 29522202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity.
    van den Berg EH; Douwes RM; de Meijer VE; Schreuder TCMA; Blokzijl H
    Dig Liver Dis; 2018 Jan; 50(1):68-75. PubMed ID: 28935188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular and metabolic disease in the liver transplant recipient.
    Kim NG; Sharma A; Saab S
    Best Pract Res Clin Gastroenterol; 2020; 46-47():101683. PubMed ID: 33158470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight Gain and
    Lattanzi B; D'Ambrosio D; Tavano D; Pitoni D; Mennini G; Ginanni Corradini S; Rossi M; Merli M
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31835505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients.
    Altieri M; Sérée O; Lobbedez T; Segol P; Abergel A; Blaizot X; Boillot O; Boudjema K; Coilly A; Conti F; Chazouillères O; Debette-Gratien M; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Kamar N; Latournerie M; Lebray P; Leroy V; Neau-Cransac M; Pageaux GP; Radenne S; Salamé E; Saliba F; Samuel D; Vanlemmens C; Besch C; Launoy G; Dumortier J
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101514. PubMed ID: 33714907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    VanWagner LB; Lapin B; Skaro AI; Lloyd-Jones DM; Rinella ME
    Liver Int; 2015 Dec; 35(12):2575-83. PubMed ID: 25977117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De-novo nonalcoholic fatty liver disease at 5 years after liver transplantation: prevalence and predictive factors.
    Tejedor-Tejada J; Valenzuela EF; Muñoz RN; Gómez LH; García-Pajares F; Álvarez CA; Sánchez-Martín F; Alonso-Martín C; Sánchez-Antolín G
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):399-406. PubMed ID: 32317584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver-Related and Cardiovascular Outcome of Patients Transplanted for Nonalcoholic Fatty Liver Disease: A European Single-Center Study.
    Van Herck J; Verbeek J; van Malenstein H; Laleman W; Cassiman D; Verslype C; van der Merwe S; Jochmans I; Sainz-Barriga M; Monbaliu D; Pirenne J; Nevens F
    Transplant Proc; 2021 Jun; 53(5):1674-1681. PubMed ID: 34016462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients.
    Losurdo G; Castellaneta A; Rendina M; Carparelli S; Leandro G; Di Leo A
    Aliment Pharmacol Ther; 2018 Mar; 47(6):704-714. PubMed ID: 29359341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management.
    Cigrovski Berkovic M; Virovic-Jukic L; Bilic-Curcic I; Mrzljak A
    World J Gastroenterol; 2020 Jun; 26(21):2740-2757. PubMed ID: 32550751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained Virological Response Is Associated with a Decreased Risk of Posttransplant Diabetes Mellitus in Liver Transplant Recipients with Hepatitis C-Related Liver Disease.
    Roccaro GA; Mitrani R; Hwang WT; Forde KA; Reddy KR
    Liver Transpl; 2018 Dec; 24(12):1665-1672. PubMed ID: 30291672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times.
    Gitto S; Marra F; De Maria N; Bihl F; Villa E; Andreone P; Burra P
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):173-178. PubMed ID: 30791778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations.
    Nasser-Ghodsi N; Mara K; Watt KD
    Hepatology; 2021 Aug; 74(2):1003-1013. PubMed ID: 33544906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis.
    Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J
    Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic Steatohepatitis After Liver Transplantation.
    Cotter TG; Charlton M
    Liver Transpl; 2020 Jan; 26(1):141-159. PubMed ID: 31610081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.